6,692
Views
22
CrossRef citations to date
0
Altmetric
Review

Paracetamol and morphine for infant and neonatal pain; still a long way to go?

, , , , , & show all
Pages 111-126 | Received 14 Jun 2016, Accepted 25 Oct 2016, Published online: 09 Nov 2016

Figures & data

Figure 1. Depiction of pain multimodality according to Loeser. Adapted with permission from: Loeser JD. Pain and suffering. Clin J Pain 2000; 16(2 Suppl): p. S2-6.

Figure 1. Depiction of pain multimodality according to Loeser. Adapted with permission from: Loeser JD. Pain and suffering. Clin J Pain 2000; 16(2 Suppl): p. S2-6.

Table 1. Validated pain assessment tools according to age and their indication.

Table 2. Potential pharmacodynamic markers in neonates and infants.

Figure 2. Schematic diagram of clinical research wi th morphine and paracetamol (white boxes) in practice. Black boxes represent new drugs to be studied. Dose finding and population PK/PD modelling with both ion into clinical practice will be possible. RCT: randomized controlled trial; pop PK/PD: population pharmacokinetics/pharmacodynamics; PCM: paracetamol.

Figure 2. Schematic diagram of clinical research wi th morphine and paracetamol (white boxes) in practice. Black boxes represent new drugs to be studied. Dose finding and population PK/PD modelling with both ion into clinical practice will be possible. RCT: randomized controlled trial; pop PK/PD: population pharmacokinetics/pharmacodynamics; PCM: paracetamol.

Table 3a. Randomized controlled trials with morphine in the young pediatric population.

Table 3b. Randomized controlled trials with paracetamol in the young pediatric population.

Figure 3. (a, d) Morphine concentrations, (b, e) morphine-3-glucuronide (M3G) concentrations, and (c,f) morphine-6-glucuronide (M6G) concentrations predicted in model-based simulations in children weighing 0.5, 1, 2, 2.5 and 4 kg and a postnatal age of <10 days (dotted lines) and children weighing 0.5, 1, 2, 2.5,4, 10 and 17 kg and a postnatal age of >10 days (solid lines) based on (a–c) a dosing regimen with a loading dose of 100 mg/kg and maintenance dose of 10 mg/kg/h and (d–f) a regimen with a loading dose of 100 mg/kg followed by an infusion of 10 mg/kg1.5/h with a 50% reduction in the maintenance dose for children with a postnatal age <10 days. Reprinted with permission from: Knibbe, C.A, et al., Morphine glucuronidation in preterm neonates, infants and children younger than 3 years. Clin Pharmacokinet, 2009. 48(6): p. 371–85.

Figure 3. (a, d) Morphine concentrations, (b, e) morphine-3-glucuronide (M3G) concentrations, and (c,f) morphine-6-glucuronide (M6G) concentrations predicted in model-based simulations in children weighing 0.5, 1, 2, 2.5 and 4 kg and a postnatal age of <10 days (dotted lines) and children weighing 0.5, 1, 2, 2.5,4, 10 and 17 kg and a postnatal age of >10 days (solid lines) based on (a–c) a dosing regimen with a loading dose of 100 mg/kg and maintenance dose of 10 mg/kg/h and (d–f) a regimen with a loading dose of 100 mg/kg followed by an infusion of 10 mg/kg1.5/h with a 50% reduction in the maintenance dose for children with a postnatal age <10 days. Reprinted with permission from: Knibbe, C.A, et al., Morphine glucuronidation in preterm neonates, infants and children younger than 3 years. Clin Pharmacokinet, 2009. 48(6): p. 371–85.

Figure 4. Metabolic pathways of paracetamol. Reprinted with permission from: Roofthooft, D.M.E., Paracetamol and Preterm Infants: a painless liaison? PhD thesis, 2015, Erasmus University.

Figure 4. Metabolic pathways of paracetamol. Reprinted with permission from: Roofthooft, D.M.E., Paracetamol and Preterm Infants: a painless liaison? PhD thesis, 2015, Erasmus University.